Non-face-to-face tx companies are appealing for regulations

Along with COVID-19

There are a lot of demands for maintenance ahead of the reduction of infectious disease levels

Non-face-to-face treatment companies are appealing for regulatory improvement ahead of the abolition of social distancing and easing the level of infectious diseases.

 

Pharmacists are protesting that the reason for non-face-to-face is disappearing and that they should take steps to temporarily terminate the permit as scheduled.

 

According to the Korea Chamber of Commerce and Industry on the 18th, the most frequent complaint among requests for improved regulations in the health and medical sectors was non-face-to-face treatment.

 

In February, the Korea Chamber of Commerce and Industry and the Ministry of Trade, Industry and Energy temporarily approved the "non-face-to-face treatment counseling service for overseas citizens" through regulatory sandbox deliberation.

 

The two approved companies are Blue Ant and Gooddoc.

 

Companies have urged regulations to improve for the continuous operation of non-face-to-face treatment services, which are limited to "temporary permission." An official from the Korea Chamber of Commerce and Industry said, "It is temporarily allowed, but there are many opinions to request improvement because it can be terminated if the infectious disease level is lowered," adding, "The MOHW does not have a regulatory sandbox, so there are many companies requesting non-face-to-face treatment." If the infectious disease level is adjusted from the existing first grade to the second grade, it is highly likely that the crisis alert will be lowered, which is a serious stage.

 

Since the government has decided to operate non-face-to-face treatment only at the serious stage, it will be completely converted to face-to-face treatment at the end of the serious stage.

 

The industry has insisted on continuous requests for improvement, but related discussions have not yet been made.

 

Discussions between the government and stakeholders are expected to take place soon because they have announced guidelines for easing quarantine for the purpose of With COVID-19.

 

There were many opinions that front-line pharmacists should stop non-face-to-face treatment by temporarily abolishing the notice of permission as scheduled, but some also suggested that non-face-to-face treatment will be maintained.

 

Pharmacist A in Seoul said, "The medical community seems to have changed its attitude a lot.

 

If non-face-to-face treatment is maintained as it is, it seems to be preparing with a focus on what authority to take," he said.

 

He worried, "The more cumulative patients the more difficult it will be to prevent." Another pharmacist said, "The reason why we allowed it in the first place was because of concerns that the number of confirmed patients could increase while visiting clinics and pharmacies.

 

Now, there is no reason to maintain it in a situation where confirmed patients go directly," he said.